As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

A Chinese chemical company, its director, and three senior employees have been indicted on charges of manufacturing and distributing fentanyl precursors and xylazine, the U.S. Department of ...

Dr. Aljadhey provided an overview of SFDA's regulatory framework and outlined investment pathways for Chinese companies ...